Vaccine Miracles: Does JNJ Kill the Profit Path for MRNA and NVAX?May 24, 2021 by admin 0 Comments Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like 3 Red-Hot Growth Stocks for Your Watch List Top Stock Picks for Week of October 20, 2025 Shopify (SHOP) and Bloomin’ Brands (BLMN): 10/21/25 Bull & Bear The Mag 7 Stock Charts: Which are Hot? United Airlines Trades Lower After Earnings